Lipid Biomarkers for Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis (ALS) is a fatal degenerative disease primarily characterized by the selective loss of upper and lower motor neurons. To date, there is still an unmet need for robust and practical biomarkers that could estimate the risk of the disease and its progression. Based on meta...
Main Author: | Jose-Luis González De Aguilar |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-04-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fneur.2019.00284/full |
Similar Items
-
Amyotrophic Lateral Sclerosis
Published: (2021) -
Cerebrospinal Fluid Chitinases as Biomarkers for Amyotrophic Lateral Sclerosis
by: Júlia Costa, et al.
Published: (2021-07-01) -
Biomarkers of Metabolism in Amyotrophic Lateral Sclerosis
by: Siobhan E. Kirk, et al.
Published: (2019-03-01) -
Extracellular Vesicles and the Quest for Molecular Biomarkers for Amyotrophic Lateral Sclerosis
by: Manser, Charlotte
Published: (2020) -
A prospective longitudinal study on the microbiota composition in amyotrophic lateral sclerosis
by: Diana Di Gioia, et al.
Published: (2020-06-01)